FDA Postmarketing Safety Upgrades Gain Momentum In Congress
This article was originally published in The Tan Sheet
Executive Summary
A new FDA drug safety office would have jurisdiction over OTC drug marketing under a proposal from Sen. Chris Dodd (D-Conn.)
You may also be interested in...
Drug Safety To Be Evaluated In Senate Health Committee Hearings
The Senate Health Committee will convene March 1 and 3 to hold hearings on prescription drug safety issues
Drug Safety To Be Evaluated In Senate Health Committee Hearings
The Senate Health Committee will convene March 1 and 3 to hold hearings on prescription drug safety issues
Drug Safety To Be Evaluated In Senate Health Committee Hearings
The Senate Health Committee will convene March 1 and 3 to hold hearings on prescription drug safety issues
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: